T-knife Therapeutics, Inc. Logo Skip to main content
  • About
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • TCR Therapies
    • MyT™ Platform
    • Scientific Publications
  • Pipeline
    • Pipeline Chart
    • TK-8001 TCR-T
    • TK-2504 TCR-T
    • Clinical Trials
  • News
    • Press Releases
  • Join Us
    • Why T-knife
    • Mission and Values
    • Job Opportunities
  • Contact

News

Recent News

8 February, 2023
T-knife Therapeutics Announces the Appointment of Behzad Kharabi, M.D., as Chief Medical Officer

20 October, 2022
T-knife Therapeutics Announces Dosing of First Patient with TK-8001 in the IMAG1NE Phase 1/2 Clinical Trial 

08 ApRil, 2022
T-knife Therapeutics Announces New TCR-T Program Targeting KRAS G12V and Presents Data at the American Association for Cancer Research (AACR) Annual Meeting

All Press Releases

Media Contact

If you are a member of the media and would like to speak with T-knife, please contact us at media@t-knife.com.

  • Home
  • About
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • TCR Therapies
    • MyT™ Platform
    • Scientific Publications
  • Pipeline
    • Pipeline Chart
    • TK-8001 TCR-T
    • TK-2504 TCR-T
    • Clinical Trials
  • News
    • Press Releases
  • Join Us
    • Why T-knife
    • Mission and Values
    • Job Opportunities
  • Contact
  • linkedin
  • Privacy Notice
  • Imprint
T-knife Therapeutics, Inc. Logo
  • linkedin
  • Privacy Notice
  • Imprint
© 2023 T-knife Therapeutics, Inc. All rights reserved.
Website Design: Hane Chow, Inc.